Cheng Q, Liu C, Chen Q, Luo W, He T, Yang D
Front Cell Dev Biol. 2023; 11:1158936.
PMID: 37283947
PMC: 10239932.
DOI: 10.3389/fcell.2023.1158936.
Lagana A, Chiantera V, Gerli S, Proietti S, Lepore E, Unfer V
Pathogens. 2023; 12(3).
PMID: 36986338
PMC: 10056139.
DOI: 10.3390/pathogens12030416.
Garcia-Perez E, Ryu D, Kim H, Kim H, Lee H
Toxins (Basel). 2021; 13(11).
PMID: 34822571
PMC: 8618226.
DOI: 10.3390/toxins13110787.
Karan D, Dubey S, Pirisi L, Nagel A, Pina I, Choo Y
J Nat Prod. 2020; 83(2):286-295.
PMID: 32022559
PMC: 7161578.
DOI: 10.1021/acs.jnatprod.9b00577.
Inada E, Saitoh I, Kubota N, Iwase Y, Kiyokawa Y, Shibasaki S
Int J Mol Sci. 2019; 20(19).
PMID: 31623314
PMC: 6801629.
DOI: 10.3390/ijms20194904.
HPV16-transformed human keratinocytes depend on SIX1 expression for proliferation and HPV E6/E7 gene expression.
Hosseinipour M, Wan F, Altomare D, Creek K, Pirisi L
Virology. 2019; 537:20-30.
PMID: 31425971
PMC: 6901751.
DOI: 10.1016/j.virol.2019.08.009.
The promise of combining cancer vaccine and checkpoint blockade for treating HPV-related cancer.
Shibata T, Lieblong B, Sasagawa T, Nakagawa M
Cancer Treat Rev. 2019; 78:8-16.
PMID: 31302573
PMC: 6710123.
DOI: 10.1016/j.ctrv.2019.07.001.
Stem Cell Properties of Normal Human Keratinocytes Determine Transformation Responses to Human Papillomavirus 16 DNA.
Woappi Y, Hosseinipour M, Creek K, Pirisi L
J Virol. 2018; 92(11).
PMID: 29593030
PMC: 5952166.
DOI: 10.1128/JVI.00331-18.
Clinical Utility of Molecular Biomarkers in Cervical Squamous Intraepithelial Lesions in a Young Adult Population.
Spiryda L, Whitaker K, Messersmith A, Banister C, Creek K, Pirisi-Creek L
J Low Genit Tract Dis. 2015; 20(1):26-30.
PMID: 26579841
PMC: 4691357.
DOI: 10.1097/LGT.0000000000000163.
A phase I dose-escalation clinical trial of a peptide-based human papillomavirus therapeutic vaccine with skin test reagent as a novel vaccine adjuvant for treating women with biopsy-proven cervical intraepithelial neoplasia 2/3.
Greenfield W, Stratton S, Myrick R, Vaughn R, Donnalley L, Coleman H
Oncoimmunology. 2015; 4(10):e1031439.
PMID: 26451301
PMC: 4590015.
DOI: 10.1080/2162402X.2015.1031439.
The translational significance of epithelial-mesenchymal transition in head and neck cancer.
Graves C, Abboodi F, Tomar S, Wells J, Pirisi L
Clin Transl Med. 2015; 3(1):60.
PMID: 25632320
PMC: 4302251.
DOI: 10.1186/s40169-014-0039-9.
Six1 overexpression at early stages of HPV16-mediated transformation of human keratinocytes promotes differentiation resistance and EMT.
Xu H, Pirisi L, Creek K
Virology. 2014; 474:144-53.
PMID: 25463612
PMC: 4259858.
DOI: 10.1016/j.virol.2014.10.010.
Six1 promotes epithelial-mesenchymal transition and malignant conversion in human papillomavirus type 16-immortalized human keratinocytes.
Xu H, Zhang Y, Altomare D, Pena M, Wan F, Pirisi L
Carcinogenesis. 2014; 35(6):1379-88.
PMID: 24574515
PMC: 4043240.
DOI: 10.1093/carcin/bgu050.
TGF-β regulation of gene expression at early and late stages of HPV16-mediated transformation of human keratinocytes.
Kowli S, Velidandla R, Creek K, Pirisi L
Virology. 2013; 447(1-2):63-73.
PMID: 24210100
PMC: 3895483.
DOI: 10.1016/j.virol.2013.08.034.
SORBS2 and TLR3 induce premature senescence in primary human fibroblasts and keratinocytes.
Liesenfeld M, Mosig S, Funke H, Jansen L, Runnebaum I, Durst M
BMC Cancer. 2013; 13:507.
PMID: 24165198
PMC: 3819711.
DOI: 10.1186/1471-2407-13-507.
Partial loss of Smad signaling during in vitro progression of HPV16-immortalized human keratinocytes.
Altomare D, Velidandla R, Pirisi L, Creek K
BMC Cancer. 2013; 13:424.
PMID: 24047375
PMC: 3848426.
DOI: 10.1186/1471-2407-13-424.
Ski protein levels increase during in vitro progression of HPV16-immortalized human keratinocytes and in cervical cancer.
Chen Y, Pirisi L, Creek K
Virology. 2013; 444(1-2):100-8.
PMID: 23809940
PMC: 3919796.
DOI: 10.1016/j.virol.2013.05.039.
Papillomavirus E6 oncoproteins.
Vande Pol S, Klingelhutz A
Virology. 2013; 445(1-2):115-37.
PMID: 23711382
PMC: 3783570.
DOI: 10.1016/j.virol.2013.04.026.
Cellular transformation by human papillomaviruses: lessons learned by comparing high- and low-risk viruses.
Klingelhutz A, Roman A
Virology. 2012; 424(2):77-98.
PMID: 22284986
PMC: 3703738.
DOI: 10.1016/j.virol.2011.12.018.
Primary human cervical carcinoma cells require human papillomavirus E6 and E7 expression for ongoing proliferation.
Magaldi T, Almstead L, Bellone S, Prevatt E, Santin A, DiMaio D
Virology. 2011; 422(1):114-24.
PMID: 22056390
PMC: 3229657.
DOI: 10.1016/j.virol.2011.10.012.